Creo Medical Group (LON:CREO) Stock Price Up 2.6% – Here’s Why

Creo Medical Group PLC (LON:CREO) rose 2.6% during mid-day trading on Tuesday . The company traded as high as GBX 19.50 ($0.24) and last traded at GBX 19.50 ($0.24). Approximately 149,612 shares traded hands during mid-day trading, a decline of 75% from the average daily volume of 598,117 shares. The stock had previously closed at GBX 19 ($0.24).

Creo Medical Group Stock Up 2.6 %

The firm has a market capitalization of £70.55 million, a P/E ratio of -325.00 and a beta of 0.86. The company has a current ratio of 3.24, a quick ratio of 2.19 and a debt-to-equity ratio of 29.96. The company has a 50 day simple moving average of GBX 18.12 and a two-hundred day simple moving average of GBX 22.03.

Insider Transactions at Creo Medical Group

In other news, insider Kevin Crofton bought 1,179,000 shares of Creo Medical Group stock in a transaction dated Friday, December 13th. The shares were acquired at an average price of GBX 17 ($0.21) per share, with a total value of £200,430 ($249,570.41). Also, insider Christopher Paul Hancock purchased 4,712 shares of the company’s stock in a transaction that occurred on Monday, January 20th. The shares were purchased at an average cost of GBX 19 ($0.24) per share, with a total value of £895.28 ($1,114.78). Insiders have bought 1,188,424 shares of company stock valued at $20,222,056 in the last ninety days. Corporate insiders own 22.43% of the company’s stock.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.